Core Laboratories N.V. (CLB)

Core Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	17.7	15.12	15.43	17.7	13.81	11.09
Cash & Short-Term Investments	17.7	15.12	15.43	17.7	13.81	11.09
Cash Growth	-32.47%	-2.00%	-12.85%	28.23%	24.47%	-15.43%
Receivables	130.73	123.07	115.1	106.74	92.87	138.11
Inventory	69.9	71.7	60.45	45.44	38.15	50.16
Prepaid Expenses	9.86	8.15	15.67	14.06	14.8	15.95
Other Current Assets	5.34	5.09	5.06	5.11	6.23	5.93
Total Current Assets	233.53	223.14	211.7	189.06	165.85	221.24
Property, Plant & Equipment	154.2	153.47	157.41	172.34	181.68	199.2
Long-Term Investments	-	4.84	4.45	4.16	4.09	3.97
Goodwill	99.45	99.45	99.45	99.45	99.45	213.43
Other Intangible Assets	6.67	6.93	7.48	8.14	8.58	17.45
Long-Term Deferred Tax Assets	70.53	69.2	68.57	70.46	72.78	67.31
Other Long-Term Assets	33.42	29.38	29.3	37.26	36.16	52.08
Total Assets	597.8	586.4	578.35	580.85	568.58	774.67
Accounts Payable	36.86	33.51	45.85	29.73	23.03	35.61
Accrued Expenses	26.93	24.73	28.25	26.76	33.08	35.06
Current Portion of Leases	11.05	10.18	11.7	12.34	11.44	11.84
Current Income Taxes Payable	8.24	7.28	3.03	6.5	8.35	6.32
Current Unearned Revenue	5.5	4.76	5.94	7.77	5.46	13.38
Other Current Liabilities	9.02	7.65	8.36	7.68	8.4	9.38
Total Current Liabilities	97.6	88.1	103.14	90.78	89.75	111.59
Long-Term Debt	147.62	163.13	172.39	194.08	261.92	306.34
Long-Term Leases	42.62	42.08	38.31	49.29	56.11	64.66
Long-Term Unearned Revenue	-	-	0.02	0.44	0.29	0.38
Long-Term Deferred Tax Liabilities	13.25	12.7	22.88	24.34	20.59	27.34
Other Long-Term Liabilities	51.02	48.31	49.99	56.84	59.98	76.29
Total Liabilities	352.11	356.59	389.4	419.85	493.01	592.53
Common Stock	0.47	0.47	1.19	1.19	1.15	1.15
Additional Paid-In Capital	113.48	110.01	102.25	101.12	41.18	51.87
Retained Earnings	132.07	120.76	85.95	68.35	50.46	160.54
Treasury Stock	-0.44	-1.45	-1.36	-4.08	-14.08	-29.36
Comprensive Income & Other	-5.31	-4.97	-3.78	-10.13	-7.2	-6.33
Total Common Equity	240.27	224.82	184.26	156.45	71.51	177.87
Minority Interest	5.42	4.99	4.7	4.55	4.06	4.28
Shareholders' Equity	245.69	229.81	188.95	161	75.57	182.14
Total Liabilities & Equity	597.8	586.4	578.35	580.85	568.58	774.67
Total Debt	201.28	215.39	222.39	255.71	329.47	382.84
Net Cash (Debt)	-183.59	-200.27	-206.96	-238.01	-315.66	-371.75
Net Cash Per Share	-3.86	-4.21	-4.42	-5.10	-7.10	-8.33
Filing Date Shares Outstanding	46.91	46.86	46.63	46.28	44.57	44.45
Total Common Shares Outstanding	46.91	46.86	46.63	46.35	44.57	44.47
Working Capital	135.93	135.04	108.57	98.27	76.1	109.64
Book Value Per Share	5.12	4.80	3.95	3.38	1.60	4.00
Tangible Book Value	134.16	118.44	77.33	48.87	-36.52	-53.01
Tangible Book Value Per Share	2.86	2.53	1.66	1.05	-0.82	-1.19
Land	-	10.65	10.65	11.4	11.4	11.44
Buildings	-	120.55	120.99	120.07	117.1	116.31
Machinery	-	284.23	288.12	285.95	280.78	277.95

Source: S&P Capital IQ. Standard template.